The association between various indicators of hospital capacity, age category, and the number of screening tests performed with case fatality rate and recovery rate during a COVID-19 disease pandemic
Vol. 62 No. 2 (2021), COVID-19
Vol. 62 No. 2 (2021)

The association between various indicators of hospital capacity, age category, and the number of screening tests performed with case fatality rate and recovery rate during a COVID-19 disease pandemic

COVID-19
https://doi.org/10.15167/2421-4248/jpmh2021.62.2.1569
Published 2021-07-30
Fakher Rahim
Clinical Research Development Unit, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Bioinfo2003@gmail.com.
Morteza Abdullatif Khafaie
Amal Saki Malehi
Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
pdf

Keywords

: COVID-19; case fatality rate (CFR); recovery rate (RR); hospital resource allocation

Abstract

Background: The COVID-19-related deaths are growing rapidly around the world, especially in Europe and the United States. Purpose: In this study we attempt to measure the association of these variables with case fatality rate (CFR) and recovery rate (RR) using up-to-date data from around the world. Methods: Data were collected from eight global databases. According to the raw data of countries, the CFR and RR and their relationship with different predictors was compared for countries with 1000 or more cases of COVID-19 confirmed cases. Results: There were no significant correlation between the CFR and number of hospital beds per 1000 people, proportion of population aged 65 and older ages, and the number of CT per one million inhabitants. Furthermore, based on the continents-based subgroup univariate regression analysis, the population (R2=0.37, P=0.047), GPD (R2=0.80, P<0.001), number of ICU Beds per 100,000 people (R2=0.93, P=0.04), and number of CT per one million inhabitants (R2=0.78, P=0.04) were significantly correlated with CFR in America.  Moreover, the income-based subgroups analysis showed that the GPD (R2=0.30, P=0.001), number of ICU Beds per 100,000 people (R2=0.23, P=0.008), and the number of ventilator (R2=0.46, P=0.01) had significant correlation with CFR in high-income countries. Conclusion: The level of country’s preparedness, testing capacity, and health care system capacities also are among the important predictors of both COVID-19 associated mortality and recovery. Thus, providing up-to-date information on the main predictors of COVID-19 associated mortality and recovery will hopefully improve various countries hospital resource allocation, testing capacities, and level of preparedness.

https://doi.org/10.15167/2421-4248/jpmh2021.62.2.1569
pdf

References

[1] Z. Wu, J.M. McGoogan, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention, JAMA 323(13) (2020) 1239-1242.
[2] M.A. Khafaie, F. Rahim, Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2, Osong public health and research perspectives 11(2) (2020) 74-80.
[3] W. Van Lancker, Z. Parolin, COVID-19, school closures, and child poverty: a social crisis in the making, The Lancet. Public health (2020).
[4] M. Ferrua, C. Sicotte, B. Lalloué, E. Minvielle, Comparative Quality Indicators for Hospital Choice: Do General Practitioners Care?, PloS one 11(2) (2016) e0147296.
[5] G. Grasselli, A. Pesenti, M. Cecconi, Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response, JAMA (2020).
[6] J. Phua, L. Weng, L. Ling, M. Egi, C.M. Lim, J.V. Divatia, B.R. Shrestha, Y.M. Arabi, J. Ng, C.D. Gomersall, M. Nishimura, Y. Koh, B. Du, Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations, The Lancet. Respiratory medicine (2020).
[7] W.-c. Dai, H.-w. Zhang, J. Yu, H.-j. Xu, H. Chen, S.-p. Luo, H. Zhang, L.-h. Liang, X.-l. Wu, Y. Lei, F. Lin, CT Imaging and Differential Diagnosis of COVID-19, 71(2) (2020) 195-200.
[8] R. Verity, L.C. Okell, I. Dorigatti, P. Winskill, C. Whittaker, N. Imai, G. Cuomo-Dannenburg, H. Thompson, P.G.T. Walker, H. Fu, A. Dighe, J.T. Griffin, M. Baguelin, S. Bhatia, A. Boonyasiri, A. Cori, Z. Cucunubá, R. FitzJohn, K. Gaythorpe, W. Green, A. Hamlet, W. Hinsley, D. Laydon, G. Nedjati-Gilani, S. Riley, S. van Elsland, E. Volz, H. Wang, Y. Wang, X. Xi, C.A. Donnelly, A.C. Ghani, N.M. Ferguson, Estimates of the severity of coronavirus disease 2019: a model-based analysis, The Lancet. Infectious diseases (2020).
[9] Worlometers, 2020. https://www.worldometers.info/coronavirus/. (Accessed 10 March 2020.
[10] World Health Organization (WHO), 2020. Search Results
Web results
Coronavirus disease 2019 (COVID-19) - World Health ...www.who.int › docs › situation-reports › 20200303-sitrep-43-covid-19.
[11] Centers of Disease Control and Prevention (CDC), 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html. (Accessed March 10 2020).
[12] R.M.A.f.H.R.a.Q. (US), Registries for Evaluating Patient Outcomes: A User's Guide [Internet], 2014. https://www.ncbi.nlm.nih.gov/books/NBK208611/.
[13] N.A. Halpern, S.M. Pastores, Critical Care Medicine Beds, Use, Occupancy, and Costs in the United States: A Methodological Review, Crit Care Med 43(11) (2015) 2452-9.
[14] A. Rhodes, P. Ferdinande, H. Flaatten, B. Guidet, P.G. Metnitz, R.P. Moreno, The variability of critical care bed numbers in Europe, Intensive Care Med 38(10) (2012) 1647-53.
[15] J. Phua, M.O. Faruq, A.P. Kulkarni, I.S. Redjeki, K. Detleuxay, N. Mendsaikhan, K.K. Sann, B.R. Shrestha, M. Hashmi, J.E.M. Palo, R. Haniffa, C. Wang, S.M.R. Hashemian, A. Konkayev, M.B. Mat Nor, B. Patjanasoontorn, K.M.K. Nafees, L. Ling, M. Nishimura, M.J. Al Bahrani, Y.M. Arabi, C.M. Lim, W.F. Fang, Critical Care Bed Capacity in Asian Countries and Regions, Crit Care Med (2020).
[16] A. Ameryoun, M. Meskarpour-Amiri, M.L. Dezfuli-Nejad, H. Khoddami-Vishteh, S. Tofighi, The assessment of inequality on geographical distribution of non-cardiac intensive care beds in iran, Iran J Public Health 40(2) (2011) 25-33.
[17] N.K. Adhikari, R.A. Fowler, S. Bhagwanjee, G.D. Rubenfeld, Critical care and the global burden of critical illness in adults, Lancet (London, England) 376(9749) (2010) 1339-46.
[18] V.O. Schepin, [The structural functional analysis of beds stock of curative preventive organizations of the state public health system of the Russian Federation], Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med (1) (2014) 15-9.
[19] M. Prin, H. Wunsch, International comparisons of intensive care: informing outcomes and improving standards, Curr Opin Crit Care 18(6) (2012) 700-6.
[20] R.o.t. WHO-China, Joint Mission on Coronavirus Disease 2019 (COVID-19), 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. (Accessed 11 March 2020).
[21] V.M. Shkolnikov, E.M. Andreev, R. Tursun-Zade, D.A. Leon, Patterns in the relationship between life expectancy and gross domestic product in Russia in 2005-15: a cross-sectional analysis, The Lancet. Public health 4(4) (2019) e181-e188.
[22] B. O'Hare, I. Makuta, L. Chiwaula, N. Bar-Zeev, Income and child mortality in developing countries: a systematic review and meta-analysis, Journal of the Royal Society of Medicine 106(10) (2013) 408-14.
[23] A.W. Stewart, E.A. Mitchell, N. Pearce, D.P. Strachan, S.K. Weiland, b.o.t.I.S. Committee, The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC), International Journal of Epidemiology 30(1) (2001) 173-179.
[24] Hongbin Li., Haijuang Feng., Jie Wang., Zhijuan Qian., J. Gu., Relationships among gross domestic product per capita, government health expenditure per capita and infant mortality rate in China, Biomedical Research 28(6) (2017) 2859-2864.
[25] J.M. Kirigia, L.G. Sambo, W. Aldis, G.M. Mwabu, Impact of disaster-related mortality on gross domestic product in the WHO African Region, BMC Emergency Medicine 4(1) (2004) 1.
[26] A. Terriau, J. Albertini, A. Poirier, Q. LE BASTARD, Impact of virus testing on COVID-19 case fatality rate: estimate using a fixed-effects model, medRxiv (2020) 2020.04.26.20080531.
[27] C.J. Murray, Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months, medRxiv (2020) 2020.03.27.20043752.
[28] G. Onder, G. Rezza, S. Brusaferro, Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy, JAMA (2020).